
Autolus Therapeutics PLC
NASDAQ:AUTL

Intrinsic Value
The intrinsic value of one
AUTL
stock under the Base Case scenario is
7.24
USD.
Compared to the current market price of 2.05 USD,
Autolus Therapeutics PLC
is
Undervalued by 72%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Autolus Therapeutics PLC
Fundamental Analysis


Revenue & Expenses Breakdown
Autolus Therapeutics PLC
Balance Sheet Decomposition
Autolus Therapeutics PLC
Current Assets | 615.8m |
Cash & Short-Term Investments | 516.6m |
Receivables | 65.3m |
Other Current Assets | 33.9m |
Non-Current Assets | 130.6m |
PP&E | 114.2m |
Intangibles | 12.5m |
Other Non-Current Assets | 3.9m |
Free Cash Flow Analysis
Autolus Therapeutics PLC
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Autolus Therapeutics PLC
Revenue
|
9m
USD
|
Cost of Revenue
|
-29.3m
USD
|
Gross Profit
|
-20.3m
USD
|
Operating Expenses
|
-188.4m
USD
|
Operating Income
|
-208.8m
USD
|
Other Expenses
|
28.9m
USD
|
Net Income
|
-179.9m
USD
|
AUTL Profitability Score
Profitability Due Diligence
Autolus Therapeutics PLC's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

Score
Autolus Therapeutics PLC's profitability score is 27/100. The higher the profitability score, the more profitable the company is.
AUTL Solvency Score
Solvency Due Diligence
Autolus Therapeutics PLC's solvency score is 54/100. The higher the solvency score, the more solvent the company is.

Score
Autolus Therapeutics PLC's solvency score is 54/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
AUTL Price Targets Summary
Autolus Therapeutics PLC
According to Wall Street analysts, the average 1-year price target for
AUTL
is 9.86 USD
with a low forecast of 5.76 USD and a high forecast of 13.65 USD.
Dividends
Current shareholder yield for AUTL is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
AUTL
stock under the Base Case scenario is
7.24
USD.
Compared to the current market price of 2.05 USD,
Autolus Therapeutics PLC
is
Undervalued by 72%.